Benjamin Natter Portfolio
Invests via Kent Lake PR LLC | Managed by Benjamin Natter
Invests via Kent Lake PR LLC
Managed by Benjamin Natter
Automatically Tracked
Leads growth and operational value creation for software and tech-enabled services companies, deploying capital across growth equity and buyout situations. Benjamin Natter brings a hybrid finance-and-operator background, having held senior roles in deal execution, portfolio operations and strategic planning. He is active in sourcing cross-border transactions, structuring minority and control investments, and working with boards to scale revenue, margins and exit readiness.
Leads growth and operational value creation for software and tech-enabled services companies, deploying capital across growth equity and buyout situations. Benjamin Natter brings a hybrid finance-and-operator background, having held senior roles in deal execution, portfolio operations and strategic planning. He is active in sourcing cross-border transactions, structuring minority and control investments, and working with boards to scale revenue, margins and exit readiness.
Investment Philosophy & Strategy
Operates an operator-driven growth equity and control-oriented buyout approach focused on software and tech-enabled services, combining deal discipline with hands-on portfolio operations. Prefers cross-border, scaling opportunities where strategic go-to-market and margin expansion can be driven through executive alignment, product-led growth and disciplined cost-to-serve optimization. Structures flexible capital solutions—minority to control—to preserve upside while enabling governance interventions. Time horizon is medium to long, targeting measurable revenue acceleration, margin improvement and exit readiness through board-level partnership, KPI-driven workplans and staged capital deployment to manage downside risk.
Operates an operator-driven growth equity and control-oriented buyout approach focused on software and tech-enabled services, combining deal discipline with hands-on portfolio operations. Prefers cross-border, scaling opportunities where strategic go-to-market and margin expansion can be driven through executive alignment, product-led growth and disciplined cost-to-serve optimization. Structures flexible capital solutions—minority to control—to preserve upside while enabling governance interventions. Time horizon is medium to long, targeting measurable revenue acceleration, margin improvement and exit readiness through board-level partnership, KPI-driven workplans and staged capital deployment to manage downside risk.
Disclaimer: This Portfolio is derived from and computed based on publicly available data from SEC filings.
Gain and growth charts are calculated per selected timeframe:
39.05%
Gain -3.28%
Monthly
1.35%
Yearly
17.5%
Drawdown
24.13%
$263.89M
Equity
Holdings
$263.89M
Investment
$193.43M
$76.11M
Profit -$8.04M
Realized
$5.65M
Unrealized
$70.46M
Dividends
$1.26M
Goals
Avg. 100% completed goals
Yearly
Gain > 5% 2026
Yearly
Gain < 20% 2026
Today
Compared To Yesterday
Gain
-3.28%
Profit
-$8.04M
Win %
66%
This Week
Compared To Last Week
Gain
-2.01%
Profit
-$5.46M
Win %
66%
This Month
Compared to last month
Gain
-2.02%
Profit
-$5.47M
Win %
66%
This Year
Compared to last year
Gain
25.86%
Profit
$54.6M
Win %
66%
DXLG Destination XL Group Inc.
+2.25%
+$1,012.17 
UEIC Universal Electronics Inc.
+1.35%
+$60,718 
TFX Teleflex Incorporated
+1.24%
+$63,600 
CLAR Clarus Corporation
+0.71%
+$1,266.78 
EHAB Enhabit Inc.
+0.07%
+$10,796.07 
HSC Harsco Corporation
-31.6%
-$1.8M 
CTEV Claritev Corporation
-7.63%
-$63,700 
QTRX Quanterix Corporation
-7%
-$215,215 
TENB Tenable Holdings Inc.
-6.13%
-$241,000 
PDFS Pdf Solutions Inc.
-5.53%
-$342,000 
MITK Mitek Systems Inc.
-5.24%
-$354,000 
CDNA CareDx Inc.
-5.12%
-$1.88M 
CCSI Consensus Cloud Solutions, Inc.
-4.88%
-$362,000.2 
BBNX Beta Bionics Inc.
-4.79%
-$103,750 
RPAY Repay Holdings Corporation
-4.77%
-$100,000 
OSUR Orasure Technologies Inc.
-4.72%
-$102,214.8 
FLYW Flywire Corporation
-4.65%
-$450,000 
NPCE NeuroPace Inc.
-4.35%
-$556,100 
UPWK Upwork Inc.
-4.29%
-$187,500 
MLAB Mesa Laboratories Inc.
-3.96%
-$680,650.96 
OABI OmniAb, Inc.
-3.7%
-$87,500 
BVS Bioventus Inc. Class A
-3.29%
-$455,091 
LUNG Pulmonx Corporation
-3.24%
-$55,569.42 
CGNT Cognyte Software Ltd.
-3.23%
-$57,000 
MTCH Match Group, Inc.
-3.22%
-$106,499.85 
VMD Viemed Healthcare Inc.
-2.86%
-$195,090 
IART Integra LifeSciences Holdings Corporation
-2.66%
-$270,750.96 
CTRN Citi Trends Inc.
-2.46%
-$184,500 
RYAM Rayonier Advanced Materials Inc.
-2.25%
-$7,683.04 
TNDM Tandem Diabetes Care Inc.
-2.18%
-$90,000 
SFIX Stitch Fix Inc.
-2.15%
-$55,000 
TLYS Tilly's Inc.
-2.13%
-$6,783.3 
SKIL Skillsoft Corp.
-1.96%
-$9,006 
INNV InnovAge Holding Corp.
-1.7%
-$265,475.93 
PNTG The Pennant Group, Inc.
-1.54%
-$562,250 
SIBN Si-Bone Inc.
-1.21%
-$60,000 
EWCZ European Wax Center, Inc.
-1%
-$5,321.51 
INGN Inogen Inc.
-0.71%
-$22,500 
GDOT Green Dot Corporation
-0.45%
-$27,846.67 
VYX NCR Voyix Corp
-0.07%
-$3,750 Events
Loading...
Dividends
Dividend Analysis
Loading...
No Data
| Trades 197 | Longs Won 97/197 49% | Profit Factor 2.1 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $2.47M |
| Average Win $1.46M | Best Trade (Oct 14) $28.76M | Sharpe Ratio -90.13 |
| Average Loss -$677,063.14 | Worst Trade (Oct 16) -$5.1M | Z-Score 0.72 (52.71%) |
| Commissions $0 | Avg. Trade Length 9m 4d | Expectancy $386,343.9 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.06% | 2.99% |
| Consecutive Losing Trades | 390 | 351 | 312 | 273 | 234 | 195 | 156 | 117 | 78 | 39 |
Hover over the desired column for a detailed explanation.
Returns
Overall, Monthly| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
| BBNX Beta Bionics Inc. | 125,000 | $2.48M | $2.06M | - | -$423,750 | -17.06% | -4.795% |
| BVS Bioventus Inc. Class A | 1M | $6.67M | $13.36M | - | $6.69M | 100.36% | -3.295% |
| CCSI Consensus Cloud Solutions, Inc. | 200,000 | $4.61M | $7.05M | - | $2.44M | 52.81% | -4.884% |
| CDNA CareDx Inc. | 550,000 | $8M | $34.79M | - | $26.8M | 335.08% | -5.122% |
| CGNT Cognyte Software Ltd. | 200,000 | $1.73M | $1.71M | - | -$23,000 | -1.33% | -3.231% |
| CLAR Clarus Corporation | 50,671 | $177,349 | $178,615.27 | - | $1,266.27 | 0.71% | +0.714% |
| CTEV Claritev Corporation | 35,000 | $1.46M | $771,400 | - | -$683,738.99 | -46.99% | -7.628% |
| CTRN Citi Trends Inc. | 150,000 | $3.94M | $7.31M | - | $3.37M | 85.56% | -2.463% |
| DXLG Destination XL Group Inc. | 102,239 | $133,933 | $46,007.55 | - | -$87,925.45 | -65.65% | +2.249% |
| EHAB Enhabit Inc. | 1.08M | $8.46M | $14.9M | - | $6.44M | 76.08% | +0.073% |
| EWCZ European Wax Center, Inc. | 133,030 | $527,514.1 | $525,468.5 | - | -$2,045.6 | -0.39% | -1.003% |
| FLYW Flywire Corporation | 500,000 | $6.01M | $9.22M | - | $3.22M | 53.56% | -4.651% |
| GDOT Green Dot Corporation | 506,303 | $6.8M | $6.18M | - | -$620,220.88 | -9.12% | -0.449% |
| HSC Harsco Corporation | 450,000 | $3.91M | $3.91M | - | - | - | -31.6% |
| IART Integra LifeSciences Holdings Corporation | 752,086 | $10.78M | $9.9M | - | -$872,419.38 | -8.09% | -2.661% |
| INGN Inogen Inc. | 500,000 | $3.61M | $3.12M | - | -$485,770.53 | -13.45% | -0.715% |
| INNV InnovAge Holding Corp. | 1.74M | $9.39M | $15.36M | - | $5.97M | 63.52% | -1.699% |
| LUNG Pulmonx Corporation | 926,157 | $1.5M | $1.66M | - | $157,447.06 | 10.49% | -3.243% |
| MITK Mitek Systems Inc. | 400,000 | $3.41M | $6.4M | - | $2.98M | 87.39% | -5.243% |
| MLAB Mesa Laboratories Inc. | 134,516 | $9.01M | $16.5M | - | $7.49M | 83.08% | -3.961% |
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
FAQ
Which stocks have generated the highest profits for Benjamin Natter?
The largest contributions to the portfolio's profits come from the following stocks: Groupon, Inc - $12.5M, GeneDx Holdings Corp - $5.84M, BrightSpring Health Services, Inc. 6.75% Preferred Stock due 2027 - $3.08M, Claritev Corporation - $3.03M, and NeuroPace Inc - $2.94M. These positions have been the main drivers of growth and have significantly impacted the investor's overall performance.
Which stocks have generated the largest losses for this investor?
The largest losses in the portfolio are associated with the following stocks: Quanterix Corporation - $6.59M, Zimvie Inc - $4.61M, Xponential Fitness Inc - $3.92M, Orion S.A - $2.61M, and Telos Corporation - $1.79M. These positions have had the most negative impact on overall performance and highlight the weaker areas of the portfolio.
What dividends does Benjamin Natter's portfolio generate?
The portfolio generates substantial dividend income, with a total of $1.26M earned over time. The largest contributors to dividend income include BrightSpring Health Services, Inc. 6.75% Preferred Stock due 2027 - $337,520, Concentrix Corporation - $238,664.94, Universal Electronics Inc - $208,176, Mesa Laboratories Inc - $86,090.24, and Match Group, Inc - $73,500. This indicates that dividends play a meaningful role in the investor's overall strategy.
How stable are Benjamin Natter's monthly returns?
Benjamin Natter's monthly returns appear quite volatile. The gap between stronger and weaker months is meaningful, which suggests that the strategy can experience noticeable swings over relatively short periods. For users assessing this profile, that usually means returns may be attractive over time, but the path can be uneven and harder to tolerate during weaker periods.
Can Benjamin Natter's strategy be considered aggressive or moderate?
Benjamin Natter's strategy can be described as moderate. It balances growth potential with risk management, showing a willingness to accept some volatility while still maintaining a relatively structured and diversified approach.
Should beginners follow Benjamin Natter's strategy?
Benjamin Natter's strategy is probably not ideal for beginners. The combination of risk, volatility, or portfolio complexity may make it harder to follow and understand without prior experience. Users who are new to investing may find it challenging to replicate or tolerate the performance swings.
2026 © Marketlog. All Rights Reserved.
